OneDigital Investment Advisors LLC Purchases Shares of 2,596 Encompass Health Corporation (NYSE:EHC)

OneDigital Investment Advisors LLC purchased a new position in Encompass Health Corporation (NYSE:EHC - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 2,596 shares of the company's stock, valued at approximately $263,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Teacher Retirement System of Texas boosted its holdings in shares of Encompass Health by 32.7% in the 1st quarter. Teacher Retirement System of Texas now owns 61,305 shares of the company's stock worth $6,209,000 after buying an additional 15,120 shares during the last quarter. Arlington Trust Co LLC boosted its holdings in shares of Encompass Health by 22.9% in the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock worth $68,000 after buying an additional 125 shares during the last quarter. Summit Trail Advisors LLC bought a new stake in Encompass Health in the 1st quarter valued at about $268,000. ABLE Financial Group LLC raised its stake in Encompass Health by 5.8% in the 1st quarter. ABLE Financial Group LLC now owns 13,256 shares of the company's stock valued at $1,343,000 after acquiring an additional 728 shares during the period. Finally, KBC Group NV raised its stake in Encompass Health by 6.1% in the 1st quarter. KBC Group NV now owns 4,557 shares of the company's stock valued at $462,000 after acquiring an additional 263 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on EHC shares. UBS Group boosted their price objective on Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a research note on Monday, April 28th. Wall Street Zen cut Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. Truist Financial restated a "buy" rating and issued a $135.00 price objective (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. KeyCorp boosted their price objective on Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a research note on Tuesday, May 27th. Finally, Barclays boosted their price objective on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. Seven research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Encompass Health currently has an average rating of "Buy" and a consensus price target of $131.50.

Insider Transactions at Encompass Health

In other news, insider Elissa Joy Charbonneau sold 4,279 shares of the stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total value of $498,974.19. Following the transaction, the insider owned 11,958 shares of the company's stock, valued at $1,394,422.38. This represents a 26.35% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Mark J. Tarr sold 118,384 shares of the stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the completion of the transaction, the chief executive officer directly owned 527,070 shares in the company, valued at $64,054,817.10. The trade was a 18.34% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 132,663 shares of company stock valued at $16,034,082 in the last quarter. Insiders own 2.00% of the company's stock.

Encompass Health Price Performance

Shares of EHC traded up $2.67 during midday trading on Wednesday, hitting $109.95. 1,873,302 shares of the company traded hands, compared to its average volume of 727,149. The stock has a 50-day moving average of $119.45 and a 200-day moving average of $106.55. Encompass Health Corporation has a one year low of $82.74 and a one year high of $123.13. The firm has a market cap of $11.08 billion, a P/E ratio of 22.72, a PEG ratio of 2.43 and a beta of 0.88. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.06 and a quick ratio of 1.06.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.18. The firm had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The company's revenue was up 10.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.12 earnings per share. As a group, sell-side analysts predict that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st were issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date was Tuesday, July 1st. Encompass Health's payout ratio is 14.05%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.